These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
741 related articles for article (PubMed ID: 26878325)
1. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats. Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325 [TBL] [Abstract][Full Text] [Related]
2. Development and evaluation of co-formulated docetaxel and curcumin biodegradable nanoparticles for parenteral administration. Pawar H; Wankhade SR; Yadav DK; Suresh S Pharm Dev Technol; 2016 Sep; 21(6):725-36. PubMed ID: 26330159 [TBL] [Abstract][Full Text] [Related]
4. Docetaxel-loaded solid lipid nanoparticles: preparation, characterization, in vitro, and in vivo evaluations. Mosallaei N; Jaafari MR; Hanafi-Bojd MY; Golmohammadzadeh S; Malaekeh-Nikouei B J Pharm Sci; 2013 Jun; 102(6):1994-2004. PubMed ID: 23558514 [TBL] [Abstract][Full Text] [Related]
5. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting. Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519 [TBL] [Abstract][Full Text] [Related]
6. Ceramide and N,N,N-Trimethylphytosphingosine-Iodide (TMP-I)-Based Lipid Nanoparticles for Cancer Therapy. Balakrishnan P; Song CK; Jahn A; Cho HJ Pharm Res; 2016 Jan; 33(1):206-16. PubMed ID: 26337769 [TBL] [Abstract][Full Text] [Related]
7. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells. Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer. Wang F; Li L; Liu B; Chen Z; Li C Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535 [TBL] [Abstract][Full Text] [Related]
9. Formulation optimization, characterization, and evaluation of in vitro cytotoxic potential of curcumin loaded solid lipid nanoparticles for improved anticancer activity. Rompicharla SVK; Bhatt H; Shah A; Komanduri N; Vijayasarathy D; Ghosh B; Biswas S Chem Phys Lipids; 2017 Nov; 208():10-18. PubMed ID: 28842128 [TBL] [Abstract][Full Text] [Related]
11. Development of docetaxel nanocapsules for improving in vitro cytotoxicity and cellular uptake in MCF-7 cells. Singh SK; Banala VT; Gupta GK; Verma A; Shukla R; Pawar VK; Tripathi P; Mishra PR Drug Dev Ind Pharm; 2015; 41(11):1759-68. PubMed ID: 25686725 [TBL] [Abstract][Full Text] [Related]
13. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo. Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689 [TBL] [Abstract][Full Text] [Related]
14. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy. Lin M; Teng L; Wang Y; Zhang J; Sun X Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex Ghassami E; Varshosaz J; Jahanian-Najafabadi A; Minaiyan M; Rajabi P; Hayati E Int J Nanomedicine; 2018; 13():493-504. PubMed ID: 29416331 [TBL] [Abstract][Full Text] [Related]
16. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines. Doktorovova S; Souto EB; Silva AM Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267 [TBL] [Abstract][Full Text] [Related]
17. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity. Wang L; Liu Z; Liu D; Liu C; Juan Z; Zhang N Int J Pharm; 2011 Jul; 413(1-2):194-201. PubMed ID: 21540085 [TBL] [Abstract][Full Text] [Related]
18. The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo. Wang P; Zhang L; Peng H; Li Y; Xiong J; Xu Z Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4802-8. PubMed ID: 24094190 [TBL] [Abstract][Full Text] [Related]
19. Sustained release docetaxel-incorporated lipid nanoparticles with improved pharmacokinetics for oral and parenteral administration. Qureshi OS; Kim HS; Zeb A; Choi JS; Kim HS; Kwon JE; Kim MS; Kang JH; Ryou C; Park JS; Kim JK J Microencapsul; 2017 May; 34(3):250-261. PubMed ID: 28557649 [TBL] [Abstract][Full Text] [Related]
20. Development and in vitro characterization of docetaxel-loaded ligand appended solid fat nanoemulsions for potential use in breast cancer therapy. Yadav S; Gupta S Artif Cells Nanomed Biotechnol; 2015 Apr; 43(2):93-102. PubMed ID: 24195582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]